German Generic Reform To Relax Pediatric Pricing
Pro Generika Has Welcomed The Decision
Germany’s Bundesministerium für Gesundheit is reworking the country’s off-patent drug legislation to allow for more flexible pricing.
You may also be interested in...
The German government has released a draft bill to remedy supply chain bottlenecks for antibiotic and oncology drugs, but Pro Generika, the country’s trade association for off-patent drugs, has urged it to apply these proposed changes to all generic medicines.
Off-patent drugs industry trade group Medicines for Europe has penned an open letter to the EU containing several suggestions for how the union might tackle supply chain pressures in the generics sector.
Rising inflation has exacerbated pressures in the off-patent drug sector, prompting Medicines for Europe and the US Association for Accessible Medicines to call for regulatory intervention to ensure the long-term sustainability of the space.